21174 ⎘
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA; Virus avirulent or attenuated
Culturing circular ssDNA viruses for the production of vaccines
#1202Adaptive mutations allow establishment of JFH1-based cell culture systems for hepatitis C virus genotype 4A
#1203Genetically stable attenuated polioviruses comprising multiple mutations in domain V of the 5′ noncoding region
#1204ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#1205Human Cytomegalovirus Latency Promoting Genes, Related Virus Variants and Methods of Use
#1206Metapneumovirus strains and their use in vaccine formulations and sequences
#1207Dengue serotype 1 attenuated strain
#1208Chimeric pestiviruses
#1209N Protein Muants of Porcine Reproductive and Respiratory Syndrome Virus
#1210Recombinant North American type 1 porcine reproductive and respiratory syndrome virus and methods of use
#1211Tuberculosis vaccine
#1212Immediate protection against pathogens via MVA
#1213ATTENUATED VIRUSES, VACCINES AND METHODS OF USE THEREOF
#1214Materials and Methods for Control of Porcine Reproductive and Respiratory Syndrome
#1215Immunotherapeutic method
#1216RECOMBINANT MULTIVALENT VACCINE
#1217Modified Vaccinia Ankara virus variant
#1218Use of conditional plasmodium strains lacking an essential gene in malaria vaccination
#1219Development of dengue virus vaccine components
#1220N-linked glycosylation alteration in E0 and E2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine
#1221METHODS AND COMPOSITIONS FOR PREPARING A UNIVERSAL INFLUENZA VACCINE
#1222Cell culture system of a hepatitis C genotype 3a and 2a chimera
#1223Methods for preventing and ameiliorating porcine respiratory and reproductive syndrome virus-associated disease by immunizing against porcine ttv infection
#1224West nile virus vaccine
#1225Circovirus sequences associated with piglet weight loss disease (PWD)
#1226Modified free-living microbes, vaccine compositions and methods of use thereof
#1227Stabilized liquid rotavirus vaccine composition
#1228Microorganisms for therapy
#1229H3 equine influenza A virus
#1230Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
#1231Modified vaccinia virus ankara for the vaccination of neonates
#1232Recombinant vectors based on the modified vaccinia ankara virus (MVA) as preventive and therapeutic vaccines against AIDS
#1233Inactivated FCV vaccines
#1234Inducible expression systems
#1235Recombinant bicistronic vectors
#1236Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E
#1237METHODS OF VACCINE ADMINISTRATION
#1238Recombinant RSV Virus Expression Systems And Vaccines
#1239COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#1240Attenuation of encephalitogenic alphavirus and uses thereof
#1241MAKING INFLUENZA VIRUS VACCINES WITHOUT USING EGGS
#1242Microorganisms for therapy
#1243HERPES SIMPLEX VIRUS MUTANT AND USES THEREFORE
#1244VACCINE FOR IN OVO INOCULATION
#1245Culturing circular ssDNA viruses for the production of vaccines
#1246Adjuvant compositions
#1247Neuraminidase-deficient live influenza vaccines
#1248Two-component genome flavivirus and uses thereof
#1249Vaccinia Virus Strains
#1250Signal for packaging of influenza virus vectors
#1251Methods for Enhancing Immune Responses
#1252Multi plasmid system for the production of influenza virus
#1253Compositions and methods for the treatment of viral hepatitis
#1254FROZEN STOCKPILING OF INFLUENZA VACCINES
#1255Nucleic acids encoding respiratory syncytial virus subgroup B strain 9320
#1256DNA COMPOSITION FOR ELICITING AN IMMUNE RESPONSE AGAINST TUMOR-ASSOCIATED MACROPHAGES
#1257Recombinant RSV Virus Expression Systems And Vaccines
#1258Methods for treating, preventing and diagnosing procine ttv infection
#1259Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
#1260Methods of stimulating an immune response against prostate specific antigen
#1261Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis
#1262Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4
#1263AVIAN VIRUS VACCINES AND USES THEREOF
#1264Construction of Recombinant Adenovirus With Genes That Codify for SAG1, SAG2 and SAG3
#1265Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#1266SEQUENCE ANALYSIS OF THE TETRAVALENT ROTAVIRUS VACCINE
#1267Methods of use for HSV-1 and HSV-2 vaccines
#1268Methods of Producing Influenza Vaccine Compositions
#1269Porcine reproductive and respiratory syndrome virus strains and compositions
#1270Pestivirus mutant for use in a vaccine
#1271Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector
#1272N protein mutants of porcine reproductive and respiratory syndrome virus
#1273Porcine circovirus type 2 vaccines
#1274Multi plasmid system for the production of influenza virus
#1275PRRSV GP5 based compositions and methods
#1276CHIMERIC HIV FUSION PROTEINS AS VACCINES
#1277Methods for the propagation of modified influenza viruses in embryonated eggs
#1278Flavivirus Vaccines
#1279Immunogenic compositions capable of activating T-cells
#1280Live attenuated metapneumovirus strains and their use in vaccine formulations and chimeric metapneumovirus strains
#1281N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine
#1282Polynucleotide fragments of an infectious human endogenous retrovirus
#1283Influenza hemagglutinin and neuraminidase variants
#1284Influenza Hemagglutinin And Neuraminidase Variants
#1285Method for producing temperature sensitive influenza A viruses
#1286Genetically Modified Attenuated Vesicular Stomatitis Virus, Compositions and Methods of use Thereof
#1287RECOMBINANT RSV VIRUS EXPRESSION SYSTEMS AND VACCINES
#1288Influenza Hemagglutinin And Neuraminidase Variants
#1289SYSTEM FOR RAPID PRODUCTION OF HIGH-TITER AND REPLICATION-COMPETENT ADENOVIRUS-FREE RECOMBINANT ADENOVIRUS VECTORS
#1290Modified Vaccinia Ankara virus variant
#1291Vaccinia virus strains
#1292Circovirus sequences associated with piglet weight loss disease (PWD)
#1293Inactivated FCV vaccines
#1294GM-negative EHV-mutants without heterologous elements
#1295Pseudoinfectious and uses thereof
#1296Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#1297Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof
#1298Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof
#1299Herpes simplex virus combined subunit vaccines and methods of use thereof
#1300Orthopoxvirus vectors, genes and products thereof
#1301Attenuated RNA virus and applications thereof
#1302Influenza hemagglutinin and neuraminidase variants
#1303Homogeneous attenuated human rotavirus population
#1304N protein mutants of porcine reproductive and respiratory syndrome virus
#1305Composition Comprising a Colloidal Synthetic Bioresorbable Vector and a Viral Vector
#1306Circovirus sequences associated with piglet weight loss disease (PWD)
#1307Functional Mutations In Respiratory Syncytial Virus
#1308Attenuated virus strains and uses thereof
#1309Attenuated chimeric flavivirus bearing attenuated japanese encephalitis virus gene as backbone
#1310Influenza Virus Vaccine
#1311Use of MVA to treat prostate cancer
#1312Modified vaccinia virus ankara for the vaccination of neonates
#1313Methods for attenuating virus strains for diagnostic and therapeutic uses
#1314Herpes simplex virus combined subunit vaccines and methods of use thereof
#1315Vaccines containing canine parvovirus genetic variants
#1316HETEROLOGOUS PRIME-BOOST IMMUNIZATION REGIMEN
#1317Circovirus sequences associated with piglet weight loss disease (PWD)
#1318PRODUCTION OF ATTENUATED NEGATIVE STRANDED RNA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES
#1319Immunogenic compositions and methods
#1320Influenza M2 protein mutant viruses as live influenza attenuated vaccines
#1321Live organism product
#1322COMBINATION VACCINE COMPRISING AN ATTENUATED BOVINE VIRAL DIARRHEA VIRUS
#1323Herpes simplex virus mutant ICP0 protein
#1324Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#1325Combination vaccine for poultry
#1326Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#1327Canine influenza virus and related compositions and methods of use
#1328West Nile viruses with mutations in the 3′ terminal stem and loop secondary structure for use as live virus vaccines
#1329Rotavirus Vaccine Inducing Heterotypic Cross Protection
#1330Enhancement of immune response to vaccine by interferon alpha
#1331Modified vaccinia ankara virus variant and cultivation method
#1332Genetically engineered swine influenza virus and uses thereof
#1333Avirulent, immunogenic flavivirus chimeras
#1334Vaccines containing canine parvovirus genetic variants
#1335Dengue virus mutant strain MBU 01-2002
#1336Mutant porcine reproductive and respiratory syndrome virus
#1337Method for inducing an immunological response in an animal
#1338Modified vaccinia ankara virus variant and cultivation method
#1339Vaccines Containing Viruses Involved in Avian Malabsorption Syndrome and Methods of Administration Therefor
#1340COLD-ADAPTED EQUINE INFLUENZA VIRUSES
#1341Attenuated influenza virus and a live vaccine comprising the same
#1342DNA-transfection system for the generation of infectious influenza virus
#1343DNA-transfection system for the generation of infectious influenza virus
#1344Construction of chimera PRRSV, compositions and vaccine preparations
#1345Highly Attenuated Pox Virus Strains, Method for the Production Thereof and the Use Thereof as Paramunity Inducers or For Producing Vector Vaccines
#1346Prime boost vaccine for the protection of equines against equine influenza
#1347Defective Influenza Virus Particles
#1348Live attenuated antigenically marked classical swine fever virus
#1349Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
#1350Pathogenic Bovine Enterovirus, Vaccines, and Diagnostic Methods
#1351Safe mutant viral vaccines
#1352Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
#1353Recombinant RSV Virus Expression Systems And Vaccines
#1354Genetically engineered cell lines and systems for propagating varicella zoster virus and methods of use thereof
#1355Chimeric flaviviruses
#1356Rabies virus vector systems and compositions and methods thereof
#1357Compositions for inducing an immune response against hepatitis B
#1358Monoparamunity inducers based on attenuated rabbit myxomaviruses
#1359Method of Vaccination Against Testicular Bvdv Infection
#1360Chimeric sindbis-western equine encephalitis virus and uses thereof
#1361Vaccines and methods to treat canine influenza
#1362Genetically engineered equine influenza virus and uses thereof
#1363Methods and compositions for live attenuated viruses
#1364Modified free-living microbes, vaccine compositions and methods of use thereof
#1365Multivalent immunogenic composition containing RSV subunit compostion and influenza virus preparation
#1366Preservation of bioactive materials by freeze dried foam
#1367STABILIZATION OF VIRAL COMPOSITIONS
#1368DNA-transfection system for the generation of infectious influenza virus
#1369Circovirus sequences associated with piglet weight loss disease (PWD)
#1370Canine combination vaccines
#1371Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
#1372CULTURING CIRCULAR SSDNA VIRUSES FOR THE PRODUCTION OF VACCINES
#1373Monoparamunity inducers based on attenuated rabbit myxomaviruses
#1374Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics
#1375Chimeric Herpes Viruses and Uses Thereof
#1376Sustained release vaccine composition
#1377Infectious Bursal Disease Virus antigenic isolates and vaccines
#1378Vaccination Against Dengue Virus Infection
#1379Immunodeficiency recombinant poxvirus
#1380Modified polymerases and attenuated viruses and methods of use thereof
#1381CANINE VACCINES
#1382Vaccine
#1383Live attenuated rotavirus vaccine for oral administration
#1384gM-negative EHV-mutants
#1385Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
#1386Attenuated chimeric flavivirus bearing attenuated Japanese encephalitis virus gene as backbone
#1387Method of immunization against the 4 serotypes of dengue fever
#1388Modulation of replicative fitness by deoptimization of synonymous codons
#1389Preservation of bioactive materials by freeze dried foam
#1390Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
#1391Influenza A virus vaccines and inhibitors
#1392Virulent systemic feline calicivirus
#1393FELINE VACCINES AGAINST AVIAN INFLUENZA
#1394Live Attenuated Dengue 3 Virus Strains
#1395Feline vaccines against avian influenza
#1396Attenuated parainfluenza virus (PIV) vaccines
#1397Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
#1398Recombinant Marek's Disease Virus
#1399Attenuated Herpes Simplex Virus Type-2, Vectors Thereof and Immunogenic Compositions Thereof
#1400Modified Vaccinia Ankara virus variant
#1401Method of immunization against the 4 dengue serotypes
#1402Peptides selectively lethal to malignant and transformed mammalian cells
#1403Influenza Hemagglutinin And Neuraminidase Variants
#1404Hemorrhagic feline calicivirus
#1405VACCINE
#1406Immunogenic composition of a homogeneous live attenuated human rotavirus population
#1407Influenza hemagglutinin and neuraminidase variants
#1408Chicken Anemia Virus Vaccine from Cell Line
#1409Attenuated influenza NS1 variants
#1410METHODS FOR PREPARING AND DELIVERING ADJUVANT COMPOSITIONS
#1411Infectious bronchitis virus vaccine
#1412Use of conditional plasmodium strains lacking nutrient transporters in malaria vaccination
#1413Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof
#1414Method of immunization against the 4 dengue serotypes
#1415Prime-boost vaccine for the protection of equines against viral infection
#1416Mutant cells with altered sialic acid
#1417Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus
#1418Cattle reproductive disease vaccines
#1419Live Attenuated Nidovirus Vaccines
#1420Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis
#1421Virulence determinant within the E2 structural glycoprotein of classical swine fever virus
#1422West nile virus vaccine
#1423Mutant G Genes of the Trout Viral Haemorrhagic Septicaemia Virus (Vhsv) and Applications Thereof
#1424Vaccines against Japanese encephalitis virus and West Nile virus
#1425Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV)
#1426Live bacteria product
#1427Rescue of mumps virus from CDNA
#1428Canine influenza virus
#1429Immunogenic Hiv Compositions and Related Methods
#1430Rescue of mumps virus from cDNA
#1431Circovirus sequences associated with piglet weight loss disease (PWD)
#1432Flavivirus vaccine
#1433Purification processes for isolating purified vesicular stomatitis virus from cell culture
#1434Peptides selectively lethal to malignant and transformed mammalian cells
#1435West Nile vaccine
#1436West nile DNA vaccine
#1437High titer recombinant influenza viruses for vaccines
#1438Immunization regimen with E4-deleted adenovirus prime and E1-deleted adenovirus boost
#1439Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
#1440Microorganisms for therapy
#1441Microorganisms for therapy
#1442Compositions and Methods Of Modulating the Immune Response
#1443Cold-adapted equine influenza viruses
#1444Culturing circular ssDNA viruses for the production of vaccines
#1445Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
#1446Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS
#1447Methods for preventing or ameliorating West Nile encephalitis
#1448Cold-adapted (CA) reassortant influenza virus
#1449Methods for preventing cattle reproductive diseases
#1450Cold-adapted equine influenza viruses
#1451Methods for prevention or amelioration of West Nile encephalitis using a West Nile DNA vaccine
#1452gM-negative EHV-mutants without heterologous elements
#1453West Nile vaccine
#1454West Nile vaccine
#1455West Nile vaccine
#1456Methods of Producing Influenza Vaccine Compositions
#1457Culturing circular ssDNA viruses for the production of vaccines
#1458Methods for preventing cattle reproductive diseases
#1459Infectious bronchitis virus with an altered spike gene
#1460Paramunity inducers based on attenuated rabbit myxoma virus
#1461Signal for packaging of influenza virus vector
#1462Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
#1463Compositions and methods of treating retroviral infections
#1464Reverse genetic system for rift valley fever virus and uses thereof
#1465Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
#1466Circovirus sequences associated with piglet weight loss disease (PWD)
#1467Recombinant viruses of the paramyxoviridae family with heterologous envelope glycoproteins
#1468Mutant vesicular stomatitis viruses and uses thereof
#1469Canine influenza virus and related compositions and methods of use
#1470Nucleic acid molecules encoding prostate specific antigen oligo epitope peptides
#1471Cold-adapted equine influenza viruses
#1472Attenuated dengue virus comprising mutations in the NS3 gene
#1473Multivalent dengue virus vaccine
#1474Vaccines and methods to treat canine influenza
#1475Circovirus sequences associated with piglet weight loss disease (PWD)
#1476Circovirus sequences associated with piglet weight loss disease (PWD)
#1477Circovirus sequences associated with piglet weight loss disease (PWD)
#1478Circovirus sequences associated with piglet weight loss disease (PWD)
#1479Vectors based on recombinant defective viral genomes and their use in the formulation of vaccines
#1480Circovirus sequences associated with piglet weight loss disease (PWD)
#1481Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142
#1482Circovirus sequences associated with piglet weight loss disease (PWD)
#1483Circovirus sequences associated with piglet weight loss disease (PWD)
#1484West nile virus vaccine
#1485Nipah virus vaccines
#1486Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
#1487Modified influenza virus for monitoring and improving vaccine efficiency
#1488Stabilizers for veterinary vaccines
#1489Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
#1490Dengue serotype 2 attenuated strain
#1491Microorganisms for therapy
#1492Infectious bovine viral diarrhea virus
#1493HIV DNA vaccine
#1494Paramyxovirus-derived RNP
#1495Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
#1496In Ovo vaccine against infectious bursal disease
#1497Dengue serotype 1 attenuated strain
#1498PRRS vaccines
#1499Modified Vaccinia Ankara virus variant
#1500HBsAg-BCG combined vaccine for intracutaneous injection and preparation method thereof